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ABSTRACT
Influence of 2,5-Hexaned i one, Acrylamide, Tri-o-totyl Phosphate,
Leptophos and Methylmercury on Endogenous Levels of Tryptophan,
Seroto nin and 5-Hydroxyindoleacetic Acid and
Serotonin Turnover Rates in Rat Brain
by
Craig H. Farr, Do ctor of Philosophy
Utah State Uni versity , 1982

Major Professor: Dr . Raghubir P. Sharma
Department: Toxicology

Several industrial and environmental chemicals cause distal
and/or central neuropathy among other diverse toxic effects.
Spague-Dawley derived rats were fed doses of 2,5 -h exanedione,
acrylamide, tri -o-tolyl phosphate, Leptophos and methylmercury
via gavage.

The dose levels and administration periods were

established in previous experiments designed to asses s clinical
neuropathy using rats trained to walk on a rotorod apparatus fitted
with an electrode floor. After intravenous injections of
3H-Tryptophan, whole rat brain homogenates were anal yzed using
liqu id scintillation an d spectrofluorometri c tech niques for levels
of tryptophan, serotonin and 5-hydroxyindoleacetic acid.

Serotonin

turnover rates were calculated using the specific activities of

vii
tryptophan and serotonin at two different time periods.

The levels of

serotonin as well as the serotonin turnover rates were unaffected
by dosages of 5 to 50 mg acrylamide/kg given daily for five days or
30 to 300 mg 2,5-hexanedione/ kg given in seven dail y doses, while
whole brain concentrations of 5-hydroxyindoleacetic acid increased
significantly in a dose-depende nt manner .

The rise in

5-hydroxyindoleacetic acid levels coup led with no effects on the other
level s in acrylami de and 2,5 -hexanedione -fed animals suggests a
possible inhibition of the energy-dependent 5-hydroxyindoleacetic
acid efflux system in the brain.

Anima l s given five doses of

Leptophos (4. 5 to 45 mg/ kg) or six doses from 30 to 300 mg/ kg
tri -o- tolyl phosphate, administered every third day, showed
slightly elevated, non- s i gnificant, serotonin turnover rates while
levels of seroto nin and tryptophan remained unchanged with a slight
decrease in 5- hydroxy indoleacetic acid levels at the highest dosages.
Levels of endogenous indole compounds in methylmercury treated rats
showed no significant differences from control values; however, the
turnover rates and leve ls of serotonin were slightly lower in the
two lower treatment levels, while t he highest dose level had no
apparent effect on turnover rates or concentrations.

Further studies

involving longer treatment periods, alternate species or examination
of discrete brain areas, may further cl arify the effects of these
chemi cals on brain bi ochemistry .

(79 pages)

INTRODUCTION
In t he past century , the chemical and pharmaceutical indust ries
have synthesized thousands of new chemicals.

More than 1,000 new

compounds are developed each year in additio n to the 40,000 chemicals
and 2,000,000 mi xtures and formulations presentl y in industrial use
(Landrigan et

a~.

, 1980) .

Amo ng the di verse array of compo unds

causing to xic effects, a number of chemicals cause central and/or
peripheral neuropathic effects.

Often the neurotoxic properties of

new compounds hav e not been recognized before their introductio n to
the marke t . Workers in the pesticide and chemical industries are
particularl y susceptib le to chemically-induced neurologic disease
while the ge neral population is also susceptab l e to increased
exposure to these and other chemicals in the environment.
Severa l neuroto xic chemicals have been shown to affect the
metabolism of biogenic amines in the central nervous system (C NS ).
Sharma (1976) reported an increase in 5- hydroxyindoleacetic acid
(5- HIAA ) in dieldrin treated mice while levels and turnover rates of
5- hydroxytryptamine (serotonin or 5-HT) were unchanged, suggesting
a possible effect of 5-HIAA efflux from the brain.

Changes in the

metabolism of 5-HT and norep inephrine (NE) may be responsible for
DDT-induced hyperthermia (H rdina

eta~ . ,

1973).

Other chemi cals ,

including metals, alter brain biogenic amine metabolic activity .
Manganese and nickel treatments depress level s of 5-HT, NE, and
dopamine (DA) in whole rat brain (Neff

e ta ~ .,

1969; Mustafa and

Chandra, 1971 ) while lead exposure increases NE synthesis rates
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coupled with lower leve ls of NE in brain tissues (Mic hae lson et a Z.,
1974; Hrdina et aZ ., 1976 ) .
The chemicals used in this study , i ncluding 2,5-hexanedione
{2,5-HD), ac rylamide, tri-o-tolyl phosphate (TOTP ) , 0- 4- bromo-2,
5-dichlorophenyl 0-methyl phenylphosphonothioate (Leptophos ) and
methylmercuric chloride (ME-Hg), represent a broad spectrum of
chemicals causing distal and/or cent ral neuropathy .

The literature

concerning their histopathological effects is very exte ns ive {Spencer
and Shaumburg, 1974a, 1974b; Chang, 1977; Davis and Richardso n, 1980;
Spencer et a Z., 1980) but they also influence brain enzyme activities .
Acrylamide reduces levels of 5-HT, NE and DA in rat brain (Di x,i t
et a Z., 1980), while mercury influences biogenic amine meta bolism

(H rdina et d . , 1976) and ami ne uptake in synaptosomal preparations
(Brac ke n et

d. ,

1981 ) .

Ava i 1ab i 1i ty of tryptophan , the precursor

fo r serotonin synthesi s is reduced after exposure to lead (Lo renzo
and Gewirtz, 1977 ) with Me-Hg (Yoshino et aZ . , 1966 ) and acrylamide
(Schotman et a Z., 1977a ) both inhibiting CNS uptake of leucine .
Several i ntermediate gl yco lyti c enzymes in the br a in
are also affected by acrylamide, 2,5-HD and Me - Hg (Damstra and Bondy,
1980 ).

Moreover, lepto phos and TOTP also show central effects through

inhibition of brain neuroto xic esterase activities (Hussain and
Oloffs, 1979; Davis and Ri chardson, 1980).
Delayed neuroto xic ity is difficult to visually assess in a
quadrapedal anima l .

Although various psyc hological and physiological

procedures have been used for these studies (Tilson and Cabe, 1978a),
accurate assessments of acrylamide-induced clinical neuropathy have
been made with a rotorod device which is inexpensi ve and easi ly
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operated (Kaplan and Murphy, 1972).
This investigation was undertaken to evaluate individual effects
of 2,5-HD, acrylamide, TOTP, Leptophos and Me-Hg on various aspects
of serotonin synthesis and metabolism (i. e. endogenous levels of
Trp, 5-HT and 5-HIAA and 5-HT t urnover rates) i n rat brains using
established spectrofluorometric and liqu id scintillatio n techniques
(Neff et al. , 1971; Marini et al., 1979).
Rotorod obs ervations provided the basis for establishing the
dosing regimes for the brain biochemistry studi es.

Neuromu scular

deficiencies were quantified based on set dose levels administered
for prescribed periods of time.
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REVIEW OF LITERATURE
Serotonin

~let abo 1ism

in the Centra 1 Nervous System

The biosynthesis of 5-HT is dependent upon the uptake of
Trp through the blood-brain barrier from the plasma.

The first

biochemical transformation involves the hydroxylation of Trp by
tryptophan-5-hydroxylase to form 5-hydroxytryptophan (5-HTP) which
is decarboxylated by aromatic-L-amino acid decarboxylase to form
5-HT (Cooper et al. , 1974 ) .

Several authors have provided evidence

that serotonin exerts proquct inhibition over its own synthesis at
the tryptophan-5-hydroxylase step (Maco n et al. , 1971; Millard
et a l ., 1972 ) .

Although Trp hydroxylation is regarded by many as

therate-li mitingstep in 5-HT synthesis, observations that suggest
that the amount of Trp available to the brain actually cont rols
5-HT synthes is include : 1) daily and parallel rhythm in the bra i n
5-HT and Trp; 2) a high Michaelis constant for Trp hydroxylase
relative to the whole brain Trp concentration; and 3) a large
increase of brain 5-HT levels and its metabolite, 5-HIAA, after
a greater systemic dose of Trp (Wur tman and Fernstrom, 1972 ) .
The principle catabolic pathway of 5-HT involves oxidative
deamination catalyzed by monoamine oxidase (MAO).

The reactant

product, 5-hydroxyindole acetaldehyde, is then oxidized by aldehyde
dehydrogenase to 5-HIAA (Cooper et al ., 1974).

The existence of

an alternative route by 6-hydroxylation has been demonstrated
(Lemberger et al. , 1971 ) , and whether or not this metabo 1i te may
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interfere with normal function of the 5- HT- containing terminals
remains to be explored.
Many compounds alter 5-HT metabolism.

When administered

systemical ly, p-chloroph enylal anine (PCPA) selectively decreases
the level of 5-HT in the brain by i nhibit ing Trp hydroxylase
activity (Koe and

\~ie ss man,

1966; Gal et aZ. , 1970), whereas 5- HT

synthes i s f rom 5- HTP remains normal (Pujol et aZ. , 1971).

The

methyl xa nt hines, caffe ine, theophy l line and theobromine, are some
of the mos t widely consumed drugs.

A single dose of caffeine

elicits a sig nif ic an t increase in both 5- HT and 5-HIAA levels i n
rat brains, after either one or five hours, while theophylline is
less potent in elevating brain 5-HT although a significant increase
is observed (Berkowitz and Spector, 1973).

The mode of action of

several mild tranquilizers has been hypothesized to be through a
reduction of 5-HT synthesis and metabolism .

Dominic (1973 ) reported

decreases in levels of brain 5- HT coupl ed with increases in 5-HIAA
after exposure to chlordiazepox i de (Librium), diazepain (Valium)
or flurazepain (Dalmane).

Other drugs alter 5-HT metabolism by

increasi ng the turnover rate as is seen with morphine (Yarbrough
et aZ. , 1973) or by decreasing 5-HT while increasing 5-HI AA levels

as with ethanol treatment (Gothoni and Ahtee, 1980).
Severa l pesticides have cause changes in the 5-HT metabolic
pathway .

Dieldrin -treated mice show no change in brain 5-HT levels

while 5-HIAA values increase

suggesti ng a possible influence of

dieldrin on 5-HIAA efflux from mouse brain (Sharma, 1976).
Conflicting reports indicate both significant increases and
decreases of rat brain 5-HT after similar doses of dieldrin (Kohli
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et a l ., 1977; Wagner and Greene, 1978).

Activity of MAO is reduced

in dieldrin treated hamster brain homogenates with increased level s
of 5-HIAA in vivo while 5-HT values increased (Willhite and Sharma,
1978).

Increases i n ra t brain concentration of 5-HIAA without

affecting that of 5-HT, which the investigators attributed to
enhanced 5-HT turnover, are seen after DDT exposure (H rdina et al .,
1973).

Other studies show increased levels of rat brain 5-HT with

similar increases in 5-HIAA in carbaryl-treated rats whi ch the
i nvestigators suggested may be due to an effect on the energy requiring membrane transport for the acid metabolite (Has san and
Santoluc ito, 1971 ).
Metals, including manganese, ni ckel and mercury, influence the
5-HT biosynthetic and metabo lic pathways .

A sig nifi cant decrease

in 5- HT levels with an accompanying lower activity of L-aromatic
amino acid decarboxylase has been reported in rats f ed subacute
doses of manganese (Kimura et a l . , 1978), while nickel-fed hooded
rats showed a signi ficant lowering of serotonin levels in both the
ce rebral cortex and basal ganglia (Ali et al ., 1980 ) .

Rat pups

exposed in utero to methylmercury (Me-Hg) and sacrificed as
28-day-old weanlings were reported to have a signifi cant reductio n
of 5-HT co ncentration in the midbrain-diencephalon with decreased
but non-si gn i fica nt levels of 5-HIAA.

Pons-medullary 5-HT values

were reduced but did not reach an acceptable level of signifi cance
(Sobotka et al ., 1974) .
Several methods have been utilized to dete rmine turnover rates
of 5-HT . Al l are based on the assumption that 5-HT and 5-HIAA
are in a steady-state, with rates of formation equal to rates of
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metabo li sm and elimi na tion .

Probenecid reduces the renal excretion

of organic acids including that of 5-HIAA (Despopo ulos and Weissbach,
1957), and injectio n of probenecid increases the brain concentrations
of 5-HIAA (Neff et aZ. , 1964 ).

The accumulation of 5-HIAA after

probenecid treatment is used as an index of serotonin turnover
rates (Neff et al., 1967) but a recent study (van Wijk et aZ .,
1979) suggests that pro benec id also increases 5-HT formation by
elevating Trp levels in rat brain.
The decline of brain 5-HI AA after MAO inhibition has been used
as an estimator of 5-HT turnover rates.

Tozer and co-workers {1966)

demonstrated that after monoamine oxidase activity was blocked with
either parglyi ne or tranylcypromine, brain levels of 5-HIAA declined
exponentiall y .
A third widely used method involves the injection of radioactive
Trp and calculating turnover rate of brain 5-HT from the accumu lati on
of 3H- 5-HT coupled with the decline of the labelled Trp (Neff et aZ .,
1971).

This method also allows the investigator to determine levels

of Trp, 5-HT and 5-HIAA in the same animals.
Overview of Clinical Neuropathy Assessment
Numerous methods for detecting neurotoxicity have been reported
i n the l iterature .

General motor activity is often used as an

indication of neurotoxic status.

Obse rvational methods, both

qual i tati ve and quantitative, and automated techniques have been
developed to assess general activity (Reiter and Macphail , 1979).
Peripheral neuropathy, in bipedal animals such as ch ickens,
is readily assessed by observation and applying an ataxic index for
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quantifi cation (Watanabe and Sharma, 1977 ).

An earl y man ifestati on

of mercury - ind uced rat peripheral sensory neuropathy is "tail
rotation", characterized by a sustained vigorous circling movement
of the tail when held by the body.

This syndrome is seen t wo t o

three weeks prior to the onset of crossing and/ or ata xia of the
hind legs commonly seen in Me-Hg poisoning (Ohi e t aZ. , 1978) .

Other

motor- involvement indices include fatige, measured by swim endurance
(Campbell, 1976) and frequency of tremor occurrence (Remington and
Ani sman, 1976).

Tilson and Cabe {1978b) have deve l oped an inclined

screen procedure in wh i ch the rat is picked up by the tail and,
f rom a distance of 3 m, is gently tossed with an upward mo t ion
toward the middle of a rectangular screen .

The animals are then

rated in abi li ty to cling to the screen on a 0 to 5 point scale .
Forelimb grip strength and hindlimb extensor response tests are
procedures which utilize strain gauges to monitor musc ular strength
by isol ating either the front or rear extremities (Cabe and Tilson,
1978; Cabe et a Z., 1978).
The abi lity of rats to mai ntain their balance on a rotating
rod (rotorod) has been used as an index to assay clinical effects
of neuroto xic chemicals (Dunham and Mi ya, 1957) .

Kaplan and Murphy

(1972) described a rotorod assembl y with a scramb led shock device,
in contact with an electrode floor, to discourage jumping from the
rotorod.

Investigations by them showed that acrylamide (50 mg/ kg/ day )

produced mean rotorod failure times of 5.3 days.

The authors

co ncluded the rotorod was a se nsitive indicator of clini cal
neuropathy . Another study of acrylamide-induced motor dysfunction,
as measured by the hindl imb extensor response and inclined screen
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tests,

sh01~ed

hindlimb impairment while no effect was seen on

forelimb grip (Tilson and Cabe , 1979).

The cumulative dose required

to induce t hese effects was 100 mg/kg compared to the 180 mg/kg
req uired for changes in ambulation and rearing in the open field
(G ipon et al ., 1977), the 420 mg/kg reported to produce failure on
the rotorod (Kaplan and Murphy, 1972) and similar level s used in a
procedure which measured the spread of the hindlimbs upon landing in
rats which were dropped from a standard height (Edwards, 1977).
Several of the procedures described require a large investment
of time and resources.

The choice of tests to use in neurobehavioral

toxicology is dependent upon several factors related to the
characteristics of the animal model, the availability of technology
and training for measuring a specific function, and the cost
effectiveness/time efficiency factors associated with the number of
animals and doses of compounds under study (Tilso n and Cabe, l978a).
Aspects of Hexacarbon Neurotoxicity
Methyl-n-butyl ketone (MN BK ) and n-hexane have been found to
cause neurotoxicity following prolonged human exposure.

A few cases

of neuropathy have been attributed to methyl - isobutyl keto ne
(AuBuchon et al. , 1979) and to cyclohexane (Lande e t al., 1976), but
these compounds have failed to produce neuropathy in experimental
animals (Spencer et a l ., 1975).

Exposure to MNBK was initially

suspected as a peripheral neuropathogenic agent subsequent to an
outbreak of neuropathy in a plant producing pl astic -coated and
color-printed fabrics (Billmaier et al., 1974; Allen et al ., 1975).
Mallov (1976) found evidence to suspect MNBK as the causative agent
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in neuropathy in spray pai nters.

Humans exposed to n-hexane as

cabinet finishers (Herskowitz et al. , 1971, shoe factory workers
(Franchini e t al. , 1978) and paper adhesive workers (Paulso n and
Waylonis, 1976) have also exhibited varying degrees of polyneuropathy.
The most common cause of hexacarbon neuropathy has been the
deliberate i nhalation vapors of laquers, solvents or glues con taining
n-hexane (Gonzales and Downey, 1972; Prockop et aL , 1974, Korobkin
e t al. , 1975).

Hexane mixtures free of n-hexane gave no evidence

of neuroto xic effects (Ega n et aZ., 1980).
Serum from guinea pigs dosed with MNBK showed three major gas
chromatography-mass spectrometry peaks which were identified as
MN8K, 5-hydroxy-2-hexanone (5 -0H- 2H) and 2,5 -hexanedi one (2,5-HD )
while n-hexa ne-exposed animals produced the same metabolites
(DiVincenzo et aZ. , 1976) .

In the rat, MNBK has been reported to

be metabolized to 2-hexa nol, 5-0H-2H and 2 ,5 -HD (D iVincenzo et aZ .,
1977).

The principal metabolites of n-hexa ne in the rat are reported

to be 1-hexa nol and 2-hexanol which are further metabolized to
2,5-HD (Peribellini et aZ. , 1978) while the primary urinary n-hexane
metabolite in· man has been identified as 2,5-HD with smaller amounts
of 2-hexanol, suggesting that n-hexa ne in men and animals follows the
same metabolic pathway (Perbellini et aZ ., 1980) ,

Since 2-hexanol

is a common metabolite of n-hexane and MNBK, this alcohol may be
considered a neurotoxic product connecting the metabolic pathways
of n-hexa ne and MNBK.

Kras avage et aZ., (1980) investigated the

relative neurotoxicity of

r~NBK,

n-hexane and their metabolites by

administering equimolar doses of each compo und by gavage.

Clinical

evidence of severe hindlimb weakness or paralysis was the endpoint
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used to determine neurotoxicity.

All test compounds produced both

clinical and histological neuropathy.

The relative neurotoxicity

of the tes t compounds in decreasing order of potency was : 2,5-HD,
5-0H-2H, 2,5-h exanediol, MNBK, 2-he xanol and n -hexane.

These

researchers also found that the neurotoxi c potency was directly
related to the amount of 2,5-hexanedione produced by each compound .
The magnitude of body weight changes paralleled the neuroto xic
potency of each compound.

Other studies have confirmed these res ults

(Spencer et a l ., 1978; Eben et al ., 1979 ) .
Neurotoxic hexacarbons produce distal axonopathies in the
longer and larger axons in both the peripheral (PNS ) and centra l
nervous system (CNS).

Earl y changes show axonal swelling with a

decrease in axonal transport (Griffin et al ., 1977) .

As the dying-

back proces s continues, the axonal swelling ascends th e nerve fiber
with a resultant focal demyelination followed by remyelination
(Powell et al . , 1978).
Neurotoxic hexacarbon compounds, 2,5 - HD and MNBK, have been
shown to inhibit brain gl ycolytic enzymes including phosphofructokinase (Sabri et al ., 1979a), glyceraldehyde-3-phosphate dehydrogenase
Sabri et al. , 1979b) and enolase, while neither compound affected
lactate dehydrogenase (Howland et al ., 1980).

These results support

the hypothesis that neurotoxic hexacarbon compounds inhibit the
activity of enzymes required for energy production.

Gilles and

co-workers (198la, 198lb) recently reported significant decreases
14
in the in vitr o incorporation of [l - c] acetate into ubiquinone
in sciati c nerve and brain of rats fed 1% 2,5-HD in drinking water
for 6 week s while acetate incorporation into phospholipids, fatty
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acids and cho lesteryl esters was simi lar in tissues of 2,5-HD- treated
rats an d pair-fed controls.

Loss of body wei ght induced by 2,5-HD

was similar to that seen in pair fed co ntro l rats.

These authors

hypothesized that since ubiquinone has been shown to transfer
electro ns between NADH dehydrogenase and cytochrome b in the electron
transpo r t chai n of the mitochondria (Rama sa rma, 1968), an inhib iti on
of oxidative - phosphory lati on co uld result fro m decreased ubi qu inone
biosynthesis.
Endogenous levels of brain indoleamines in neurotoxic
hexacarbon-treated anima l s have not been reported i n the literature .
Aspects of Acrylamide Neu roto xicity
The major use of acrylamide is as a vinyl monomer in t he
production of high molecular polymers which are useful f l occu lators.
Ac rylami de became commercially important in the early 1950 's with
applications in min ing ope rations, purification of water supp lies
and disposal of industrial waste.

About the same time acrylamide

was used as a strengthener in the ma nufacture of paper and cardboard
(McCollister et al ., 1964), as well as a grouting agent in min ing
and tunnel construction {Ful lerton and Barnes, 1966).
The neurotoxic chara cte ristics of acrylamide were di scovered
soon after the substance wa s manufactured.

Observations showed that

th e acrylamide monomer was neurotoxic, but when polymerizatio n
occurred the product was no longer tox ic {Spencer and Schaumburg,
1974a), which limits the exposed population of workers to those
involved in manufacture of the monomer or in the polymerization
process (Garl and and Patterson, 1967).

Intoxications have occurred
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during grouting operations conducted in confined spaces when the
mo nomer is pumped into the soil and, with the addition of catal ys ts,
in situ po lymerization occurs .

Auld and Bedwell (1967 ) provided

the first clin ical description of a worker intoxicated in this way
and, more recently, fou r men working together in a tunnel were
simila rl y affected (Kesson et aZ ., 1977).

Spencer and Schaumburg

(1974a ) concluded that most instances of industrial toxicity have
resulted f rom dermal absorption rather than inhalation.

The only

report of to xicity unrelated to work was to a family in Japan who
developed acute toxicity after their well water became co ntaminated
with acrylamide used in nearby underground construction (Igisu
et aZ. , 1975).

Following remova l f rom exposure, which is the only

effective remedy known , affected persons showed a reduction of
symptoms.

In patients with mild neuropathy, complete recovery may

be expected (Garland and Patterson, 1967; Kesson et aZ . , 1977 ) while
in those more severe ly affected, there may be residual abnormalities
(Fullerton, 1969).
Kuperman (1958) published one of the first reports of acrylamide
to xicity in animals.

He investigated intoxication in cats and

reported the cumulative nature of acrylamide and demonstrated the
effect was not dependent on the route of administrat i on.

Kuperman

al so studied changes in cerebra l electrical activity, but pathological
studies showed no abnormalities in the central nervous system .

In

1964, McCollister and cowo r kers did further work with acrylamide on
rabbits, cats, monkeys, guines pigs and rats,

The functional effects

were similar to those seen before, and again no central nervous
system pathology was see n.
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Repeated acrylamide exposure produces a bilater al , dis tal
neuropathy.

More distal axons innervating the hindlimbs are affected

by acry l amide before those more proximal which correlates with motor
deficits first seen in the hindlimbs (Spencer and Schaumbur g, 1975 ) .
Though systematic study of the pattern of nerve damage in exper imental
animals demonstrated that distal regions of nerves are more severel y
affected than prox imal areas, distal fiber degeneration is seen in
conjuncti on with proximal preservation (Fullerton and Barnes, 1966 ).
The term "dying-back" is used to describe the pattern of slow,
progressive retrograde degeneration seen with acrylamide intoxication
(Prineas, 1969; Schaumburg et al. , 1974).

Long and large myelinated

fibers are affected more than short and thin fibers with t he most
severe damage near blood vesse l s (Suzuki and Pfaff, 1973).

Initial

motor ne rve termi na 1 degeneration is widespread and not restricted
to the terminals of the longest axons (Jennekens et al ., 1979 ) .
Schaumburg and co -workers detected the earliest morphological
changes in nerve terminals of Pacinian corpuscles i n the foot pad
followed by degeneration of nerve endings in the muscle spindles
{1974 ).

It is also known that in dying-back syndrome, axononal

degeneratio n occurs in long fiber nerve tracts of the central nervous
system including regions of the medulla, spinal cord and cerebellum.
Deplet ion of brain biogenic amines, including NE, DA and 5-HT
has been observed following nine daily 50 mg acrylamide/kg
intraperitoneal injections (Dixit et al. , 1980).

Acrylamide-treated

chick ganglia cell cultures showed morphological alterations of
neurons and neuroglia which could be prevented by addition of
various nucleotides or cofactors (Sharma and Obersteiner, 1977 ) .
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Several biochemical effects are seen in acrylamide intoxication.
A significant depression of leucine incorporation into brain proteins
has been corre lated with the progress of acrylamide neuropathy
(Schotman et aZ ., 1977a ) , while similar findings were observed in
the incorporation of labelled lysine and methionine in the spinal
cord (Hashimoto and Ando, 1973).

A decrease in spinal cord and

brain stem protein synthesis rates has been demonstrated with acute
and chronic acrylamide intoxication (Schotman et aZ ., 1977b ).
Acrylamide has also been shown to reduce the act ivi ties of brain
glyceraldehyde-3-phosphate-dehydrogenase, phosphofructokinase and
neu ronal specific enolase in the glycolytic pathway.

These studies

were based on the proposal by Spencer and Schaumburg (1975) that the
multiple axonopathy seen after acrylamide i ntoxicatio n is caused
by 1) impair_ed axonal transport, 2) failure of the synthetic
machinery in the neuronal cell bodies, and/or 3) changed in axonal
met abo 1ism.
Aspects of Organophosphorus Neurotoxicity
Organophosphorus (OP) compounds have been shown to affect both
the central and peripheral nervous systems.

Inhibition of

acetylcholinesterase (AChE),with the resultant effects, has been
widely studies and reviewed (Eto, 1974).

Many OP compounds have

been shown to produce a central -peripheral distal axonopathy similar
to the axonal degeneration seen with acrylamide and neurotoxic
hexacarbons (Cava nagh, 1973; Bouldin and Cava nagh, 1979) : This
effect is not dependent upon the inhibition of AChE but a strong
correlation has been made involving the i nhibiti on of another
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esteratic enzyme, neuroto xi c esterase (NTE ) , a membrane bound
nerve- cell protein.

Neu rotoxic esterase is present in va ri ous brain

regions, and in spinal cord and sciatic nerve, and is inhibited by
phosphorylating a serine residue within i ts active site (Jo hnson,
1975 ).

Reactions of NTE with several carbamyl and phosphinyl esters

produce NTE inhibition without the resulting neurotoxic effects.
Johnso n (1 976) suggested that these compounds may provide a
protective function by occupying the NTE active site.

Although NTE

has been identified as the target enzyme for neurotoxic OP compounds
in the nervous system, the physiologi ca l role of this enzyme is
unknown.
Alterations of centra 1 neurotransm"i tter 1evel s have been
resported after exposure to some OP compounds.

Cerebral cortex

levels of DA and NE in parathion-fed rats were reduced (Fiscus and
Van Meter, 1977 ) while disulfoton reduced rat hippocampal NE levels
(Holt and Hawkins,

1978) .

Severa 1 widespread huma n i ntoxi cations have occurred with TOTP,
also referred to as tri-o-cresyl phosphate (TOCP), which i s
commonly used as a lubricating oil addit i ve.

The most serious human

exposure to TOTP was in 1930 when thousands of people in the southern
U.S .A. exhibited symptoms of paralysis.

Al l had ingested varieties

of "Jamaica ginger" to which substances had been added to enhance
the potency (Da vies, 1963) and subsequent analysis showed that all
compounds which caused paral ysis were found to be contaminated with
TOTP (Smith et al ., 1930; Burley, 1931) which gave this syndrome the
name, Ginger Jake.

Many poisonings relating to the accidental or

deliberate addition of tricresylphosphates to edible oi ls occurred
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during the following several years (Mednikyan and Mirzoya n, 1936) .
Smith and Spaulding (1959 ) described a mass poisoning in Meknes,
N. Africa affect ing 10,000 people when they ingested a mixture of
olive oil an d lubricating oils containing a hig h amou nt of TOTP.
Other cases of TOTP neuropathies have occurred in the Fiji Islands
(Soroki n, 1969) and in workers of the Spani sh shoe industry
(Bermejil l o, 1971 ) .

An outbreak of acute polyneuropathy affected

more tha n 20 young females in Sri Lanka during 1977-78 .

The illness

was seen only in girls, soon after menarche and is related cu ltural ly
to the custum of restricting meat and fish in the diet du rin g that
period and su bstituting raw eggs and gi ng i l i oil which is not
norma ll y eaten because of its cost.

Each woman was given one or

two doses of TOTP-contaminated oil dail y for two weeks (Senanayke
and Jeyaratnam, 1981 ) .

Unfortunately, the prognosis for recovery

from organophosphate neuropathy is poor due to the degeneration of
long-tracts in th e sp inal cord (Morga n and Penovich, 1978).
The ability of TOTP to cause neuropathy is dependent upon the
a - hydroxylation of a ring s idecha in followed by the formatio n of
a cyc lic phosphate ester in conjunction with the expulsion of a
tolyl ring.

If the side chain is i n the para or meta position,

cycliz ation do es not occur, but, instead further oxidation to an
acetyl group takes place (Eta et a Z. , 1962 ) rendering these compou nds
inactive for ne uropatho genic activity (Aldridge, 1954; Hine et a Z. ,
1956) .
Leptophos or Phos vel (o -4-b romo - 2 ,5-di ch l oro phenyl 0-methyl
phenylphosphonothioate) has been imp l icated i n the death and/ or
p·a ralysis of a large number of water bu f f alo in Egypt (Abou - Donia
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et aZ ., 1974) as well as possible human paralysis (Abou- Donia and

Graham, 1978) .

Leptophos has been reported to be an inhibitor of

NTE (H ussa i n and Oloffs, 1979).

These same researchers repo rted

that rats fe d doses of 5,0 mg Leptophos / kg showed neither signs of
ataxia nor hi stological alterations but did have a signi ficant
weight decrease.

Chickens dosed orally or by topical application

to the comb were affected by paralysis, loss of weight, plasma
cholinesterase inhibition and increased activity in plasma acid
phosphatase (Abou- Do nia and Preissig , 1976; Abou-Donia and Graham,
1978) .

Herin and co-workers (1978) reported that mal lard ducklings

showed a similar respo nse after Leptophos exposure.
The neuropatho l ogy of Leptophos is similar to that seen after
TOTP exposure i .e . paral ys is correlated with the degenerati on of t he
anterior des cending tract of the spinal cord and degeneration of the
sciatic nerve (P rei ss ig and Abo u-Donia, 1978) .
Aspects of Methylmercury Neurotoxicity
Industrial processes account for over 20,000 tons of merc ury
being released into the environment each year (Magos ,

1975).

Amo ng

mercury compounds, Me -Hg is known to be more neurotoxic than
inorganic mercury (Berlin and Ullberg, 1963) .

Initial indications

of a pu blic health threat caused by Me-Hg exposure came after an
epidemic in Japan had affected 126 people, with 46 deaths, mo stl y
fishermen and their families.

The cause was traced to Minamata

Bay effluents from a chemical factory utilizing mercuric chloride
as a catal ys t in the manufacture of vinyl chloride.

Consump -

tion of Me-Hg- treated seed grain has also produced several
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epidemics of neurotoxicity in humans.

The most catastrophic episode

occurred in 1972 in Iraq where thousands were hospitalized and 459
people died after eating contaminated grain (Marsh, 1979).
Impairment of the blood-brain barrier has been demons t rated
after injection of trypan blue dye or fluorescein-labelled albumin
into the nervous system of mercury-treated rats (Steinwall and
Klatzo, 1966 ) .

Chang and Hartman (1972) have demonstrated the

disposition of mercury within many biological membraines after
mercury exposure.

Several studies show that the increased

permeability and dysfunction of the blood brain barrier after mercury
intoxication is probabl y due to damage of the endothelial and glial
membranes by the mercury ions forming cross-linkages with a cell
membrane protein moiety, resulting in the leakage of plasma solutes
(Ware et aZ. , 1974) and a reduction of the uptake of amino acids
(Steinwall and Klatzo, 1966).
Distri bution studies showed that after chronic, continuous
administration of radio-labelled methylmercuric hydroxide to rats,
the spinal dorsal ganglia contained the highest concentration of
mercury, followed closely by the cerebral cortex and the cerebellum,
then by the subcortical part of the forebrain (Somjen et ai .,
1973).

Cerebellar changes in rats, after exposure to Me-Hg i n uter o ,

have shown disintegration in the endoplasmic reticulum and Golgi
complex in Purkinje cells {Spyker and Chang, 1974).

The sensory

neurons of the dorsal spinal ganglia were found to be extremely
sensitive to the toxicity of mercury.

Changes included the

disintegration of endoplasmic reticulum and ribosomes (Herman et a i .,
1973) which supports the discovery of a reduction of RNA (Chang
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eta~ .,

1972) .

Pathological examination of peripheral nerves of

Me-Hg-treated rats showed swelling and degeneration of Schwann cells
with notab l e changes in both myelin sheaths and axons whi ch tend to
begin at the nodes of Ranvier (Miyakawa

eta~ .,

1970).

Myelinated cultures of cerebellum were sensitive to exposure to
methylmercuric acetate.

Severe vacuolar degeneration was observed

in nerve cells, particularly in granule and Purkinje cells while
axons and myelin sheaths also underwent a considerable degree of
degeneration (Kim, 1971 ) .

Sharma and Obersteiner (1981) have also

reported a dose-dependent cell growth inhibition in mercury-exposured
chick ganglia cultures.
Several glycolytic enzyme activities are affected by Me-Hg .
Using histochemical techniques, Chang et aL (1973) demonstrated
a decrease in the activities of succinic dehydrogenase.

Levels of

glucose-1-phosphate and glyceraldehyde phosphate have been shown
to be increased one hour after mercury administration (Patterson and
Usher, 1971 ) .
Other biochemical effects of methylmercury show decreased
levels and turnover rates of acetylcholine (Kobayashi

eta~. ,

1980).

In 28 day old rat pups exposed in utero to 2.5 mg methylmercuric
chloride/kg from day six through day five of gestation, decreased
cholinesterase activity was found in the telencephalon and cerebellum
while reduced

levels of serotonin and norepinephrine were seen in

the midbrain-diencephalon region (Sobotka

et a ~ .,

1974) .
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METHODS
Experimental Animals
Male Sprague-Dawley derived rats [Sim:(SD)sBR], weighing 120
to 140 g were obtained from Simonsen Laboratories, Inc. of Gilroy,
CA.

Upon arrival the animals were randomly assigned to groups,

earmarked, and placed in po l ycarbo nate rat cages with screened pine
shavings as bedding.

Laboratory feed (Wayne Lab-Blox, Allied Mills,

Chicago, IL) and water were provided ad libitum.

All animals were

acclimated at least 10 days to the animal care facility maintained
under constant environmental condit ions (22±2°C, 45 -60% relative
humidity and illuminated 12 hr/day beginning at 7 a.m.)
Distal Neuromuscular Pathology Assessment
The rotorod apparatus (Figu re l) was similar to one described
by Kap lan and Murphy (1972) .

The dimensions were 0.92 X 0.46 X 0.61

M (length X width X depth) with the enclosure divided into three
compartments of equal size.
for ease of observation.

An acrylic-plastic front wall was used

A wooden dowel (7.62 em diameter) was

placed 33.0 em above the floor, which was fashioned of stainless
steel rods (0 . 64 em diameter) placed l .57 em apart at the centers.
The electrode floor was supplied with an elecritcal potential through
a scrambled shock device.

The speed of the belt-driven rod was

varied using different combinations of pulleys on the shaft of the
dowel and, a 25 rpm, constant-speed motor.
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For the first few days , a speed of 12 rpm was utilized to
train the rats, while the final testing speed was 20 rpm . Rat s
with normal neuromuscular status could perform well without
distractions or attempts to jump from the rotorod .

After a 7-10

day training period, rats were randomly assigned to four groups
of five an imals each.

To be considered normal in neuromuscular

fu nction, each rat was required to walk on the rotorod for at
least 1 min during any of three attempts on the testing days.
Al l compounds were administered by gavage with a 3 in.,
16 gauge feeding need l e, bent slightly at the ball end .
case, intubuation was after the rotorod testing.

In each

The dosages

were designed to elicit a clinical neuropathy in the highest dose
groups with no observable effects in the l owest dose groups.

Three

dose levels and a control were used in each study, while the vehic l e
varied according to the solubility of the test chemica l .

Dosing

solutions were prepared such that each animal received 1 ml/100 g
body weight with the doses measured to the nearest 0.1 ml.
Levels of 3.0, 1.0 and 0.3 g 2,5-hexanedione (Eastman grade,
Eastman Kodak Co., Rochester, NY)/kg made up in propylene glycol and
acrylamide (Eastman grade, Eastman Kodak Co.) doses of 50,15 and
5 mg/kg prepared with water , were admin i stered daily along with the
appropriate vehic le controls.

Solutions of Leptophos (98% analytical

standard, Chern Service Co . , Westchester, PA), tri-o-tolyl phosphate
(practical grade, Eastma n Ko dak Co.) and Methylmercuric (II) chloride
(95%, Ventron Corp ., Danvers, MA) were give n at three day intervals.
Leptophos was dissolved in propylene glycol in doses of 90, 30, and
9 mg/kg.

One hour prior to receiving Leptophos, the animals were
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inject ed IP with 50 mg/kg (0 . 5 ml of a 20 mg/ml solution ) atropine
sulphate (S igma Chemical Co., St. Louis, MO).

Solutu ion s of TOTP

were solubilized in oil and administered at levels of 1.0, 0.3 and
0.1 g/kg.

Dosages of 10.0, 3.3, and 1.0 mg/kg Me-Hg were made

by dissolving 10 mg Me-Hg/ml in 95% ethanol.

The fin al mercury

so lutions were prepared in corn oil containing 95 % ethanol .
Bi ochemi ca 1 Studies
From the results of a rotorod testing, the dosages and duration
of dosing in a separate set of animals for biochemical evaluations
were establ ished as shown i n Table 1.

Each of the dose groups for

the various compounds had 14 rats, except acrylamide, which had 16
in each group.

On the day following the last treatment, tai l vein
injections of 0.050 mCi (0.20 ml) L-[ 3H(G)]-tryptophan (7 .88
Ci / mmol, obtained through New England Nuclear, Boston, MA) were
administe red. The specific activity of 3H-Trp shows linear decline
over time (Neff et aZ ., 1971 ), and after one hour, half of the an imals
i n each dose level were guillotined, while the remainder were
decapitated after two hours.

The data showing the decline of 3H-Try

specific activity was reconfirmed to establish sacrifice periods.
Brains were quickly removed, frozen on dry ice, and stored at
-80°C until assayed.

The acrylamide-treated animals were sim ilarl y

sacrificed in two groups after 40 min and two hours, respectively .
The injec tions were consistently timed for sacrifice to coincide with
the third and fourth hours of the light cycle.
CoZumn Separation procedures followed in the separation of Trp ,

5-HT and %-HIAA were based on a method developed by Costa et aZ.

TABLE l
COMPOUNDS AND DOSAGE S USED IN BI OCHEMI CAL STUDI ES

Compound

2,5-hexanedione
Acrylamide

TOTP

me d.

low

CH 3CH(CH 2 )2CHCH 3

300

100

30

CH 2 = CHCONH 2

50

15

45

15

300

100

0

0

II

II

Frequency

Total
Number
of Doses

propylene
glycol

daily

7

5

H20

daily

5

4.5

propylene
glycol

every 3rd day

5

corn oi 1

every 3rd day

fi

every 3rd day

5

Cl

Or-o-t(Br

~CH OCH3
Cl
3
0....._ -;::;- 0 CH
o"P' o o
OcH3

methyl mercuric
chloride

Vehicle
high

s
Leptophos

Dosages (mg/kg)

Structure

CH -Hg-Cl
3

::::,...

30

I
10.0

3. 3

1.0 10% ethanol
in corn oil

"'
U1
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(1968) and later modified by Mar ini et al . (1979 ) to include 5-HIAA .
Columns constructed f rom Pyrex glass ,

me ~s uring

fu sed to a reservoir wi th a capacity of 10 ml.

6 mm x 120 mm , were
The column outlet

was narrowed to accomodate a 25 em length of Tygo n tubing (2 mm !D ) ,
used to regulate the flow rate depending on the height of the tubing.
Dowex 50X- X4, 200-400 mesh size , a strongly acidic cation exchange
resin, was obtained from Sigma Chemical Co. (St. Louis, MO ), subjected
to a thorough washing and pa cke d into the columns which had been
loosel y plugged with a small piece of cotton to support th e resin .

The

col umns were packed to a height of 3511l11 with resin in the hydrogen form.
Al l chemicals were reagent grade unless otherwise indicated .
Water was pu rified by deionization and reverse osmosis .

Whole brains

were homogenized in 0.4 N HC10 4 with l mg / ml Na 2s2o, at 0°C, using
a Teflon and glass apparatus. Five ml of HC10 4/Na 2s2o solut i on per
gram of brain tissue were used in each case.

The homogenate was

centr ifuged {14,000 x gat 0°C fo r 15 min), after which the
supernata nt of ea ch sample was decanted into individual 50 ml
plastic centrifuge tubes followed by pH adjustment to 2.0- 2.5 with
5 N KO H.

During a five min storag e in an ice bath, KC10 4 was

precipitated after which the mixture was centrifuged {8 .000 x g at
0°C for 10 min) to allow separation.

An aliq uot {4.9 ml ) of each

supernatnat, as well as a l ml distilled water rinse, were added
to the column reservoir.

The supernatnat was passed through the

resin followed by a series of eluting s.o lutions (Table 2).

Internal

standards of Trp, 5- HT and 5-HI AA (all obta ined through Sigma
Chemica l Co. , St. Lou is, MO) were processed in a similar fas hion
using a mock homogenate consisting of 1.31 g NaCl and 100 mg

TABLE 2
FLOW CHART FOR SEPARATION OF INDOLE COMPOUNDS l!ITH DI)WEX 50-X4 RESIN
Elution solutions

Compounds in Effluent

Supernatant, pH 2-2.5 and 1 ml H2o rinse .
7 rnl 60% methanol - H20.

1.

Supernatant.

2.

5HIAA for assay.

3.

9 ml 0.1 m sodium phosphate buffer, pH 6.5.

3.

Trp for assay.

4.

2 ml 1 N HCl .

4.

HCl wash.

Discard.

5.

6 ml 4 N HCl .

5.

HCl wash.

Discard.

6.

2 ml H 0.
2

6.

7.

6 ml 0.5 m Na 3Po 4 .

7.

H2o wash. Discard .
5HT for assay.

8.

5 ml resin washes with H20, 4 NHC l and sodium
phosphate buffer.

8.

Resin washes.

1.
2.

Discard .
Discard first 0.5 ml.
Discard first 2 ml.

Discard.
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Na 2s2o5 prepared to a total volume of 100 ml wHh0 .4 N HCl 0 .
4
Fluorometric assays were performed us ing an Aminco-Bowman
Spectrofl uorometer with the slits set at 4 mm and the photomulti plier
set at 4 for all assays.

A modification of the o-pthaldialdehyde-

co ndensate me thod of Atack and Lindquist (1973) was used to assay
5- HIAA.

Two thoro ughly mixed, l ml po rtions of each sample effluent,

one for the sample, the other for the oxidized blank, were taken .
After addition of 0.1 ml H20 to t he sample, 0.1 ml of cysteinepotassium ferricyanide sol ution (equal vo lumes of 6% cystei ne and
0.2% K3Fe(CN) 6 ) was added and mi xed.

When ready for assay, 1.4

ml cone . HCl and 50 \.1 1 0.3% o-pthald i al dehyde (O PT ) were added and
The oxidized blank was then formed by mixing 0.1 ml H2o and
0.2 ml cone. HCl to the secon d 1 ml sample al iquot . Noting the time ,
mi xed.

50

~l

of the 0.2% K3Fe(CN) 6 solution was added and mixed followed
after 10 min by 50 \.l l of the 6% cys teine . Afte r the so luti on was
mixed, 1. 2 ml cone . HCl and 50 \.1 1 of the OPT solutio n were added and
shaken.

The solutions were heated for 20 min in a water bath set at

78°C after which they were cooled in room temperature water for 3 min,
mixed thoroughly and read at excitation and emission wavelengths
of 360 nm and 480 nm, respectively.
£- tryptophan assays involved an extraction of the fluorescent

derivative as outlined by Marini et al ., 1979.

A 2.6 ml aliquot was

taken from each of the pH 6. 5 phosphate buffer column effluents and
placed in a 8 ml screw-cap tube.
phosphate buffer.

Blan ks co nsisted of 2.0 ml of the

A 50 \.1 1 aliquot of 18% formaldehyde solutions was

mi xed i nto each tube followed by 50 \.l l of 0.01 M FeC1 3 in cone . HCl .
The tubes were mixed, covered with marbles and placed in a 100°C oil
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bath.

After one hr. the tubes were removed from the bath and placed

in cold tap water for a few minutes, followed by a thorou gh mixing,
addition of 0. 2 ml 5 N KOH and a second mixing.
Washed ethyl acetate (4.5 ml) was added to each tube.

The tubes

wer€ tightly capped, shaken for 10 min and centrifuged 5 min at 2500
rpm.

A 3.0 ml aliquot of the ethyl acetate layer was transferred to

an 8 ml screw-cap tube containing l . 5 ml 0. l N HCl . These tubes
were capped, shaken 10 min, and centrifuged 5 min at 2500 rpm after
which the ethyl acetate layer was carefully aspirated from the tubes.
The HCl extract was assayed directly with excitation and emission
wavelengths of 376 nm and 458 nm, respectively.
Ser ot onin is not stabl e in strong base (Na P0 ) so the extraction

3 4
procedure (Marini et al ., 1979) was performed shortly after the samples
were eluted from the columns.

After a thorough mixing, 4 ml of each

sodium phosphate effluent was taken for assay, placed in a 50 ml
polypropylene tube and mi xed after each addition of l .5 g NaCl, 2.0 ml
borate buffer and 15 ml ethyl acetate.

The samples were shaken 10

mi n, and centrifuged 5 min after which 12 ml ethyl acetate were
transferred to tubes containing l .5 ml 0.1 N HCl and 25 ml cyclohexane.
After shaking 10 min and cent rifuging, the combined organ i c phase
was removed by aspiration.

The resulting HCl extract was assayed as

out l ined by Karasawa et a l. , 1975 . A 1.0 ml portion of the HCl
solution was combined with 0.05 ml 6% L-cysteine hydrochloride,
vortexed and mixed with l .5 ml OPT solution (10 mg % in cone. HCl).
An oxidized blank was made by combini ng a l ml aliquot with 0.02 ml
of 0.1 M ethanolic iodine for 15 min at room temperature.
then treated, in a similar fashion, as a sample.

This was

These solutions were
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all heated at 75 "C for 10 min .

After coo ling in tap water for 2

mi nu tes , the solu tions were assayed on the spectrofluorometer at 355
nm and 480 nm as the excitation and emission wavelengths, respectively.
3
3
Radiometric assays. Radioactive samples of H-Trp and H- 5-HT
were made up to 30% aqueous suspensions using 0.6 ml of the
respective phosphate effluent and l .2 ml H20 with 4. 2 ml f l uor
solution cons ist ing of scintillation gr ade to luene :Triton X-1 00
(2:1 ) and 7 g/ l 2a70 fluor (98% PPO, 2" bis-MSB, Research Products
Inte rnati onal , El k Grove Village, IL) .

The vi a l s were mixed, placed

in a 40 "C water bath for 30 min, mixed aga in and placed in a Packard
2660 tri-carb scintillation co unter to equilibrate to the l ower
temperat ure (l2 "C) and darkness for at least six hours prior to
counting.

The samples were co unted 10 min. using a samp le cha nnel s

ratio efficiency correction program which was calibrated with
mi ni- vial standards.
Data Analysis
Levels of Trp, 5-HT and 5-HI AA expressed as nmol /g whole wet
brain and 5-HT turnover rates (nmol/g/hr) were calculated using
external standards in co njunc tion with derivatization procedures.
These numbers were then multiplied by the inverse of the fractional
recovery and by t he in verse of the grams of tissues per sample to
calculate the nmo l / g values for each compo und as follows:
nmol indole compound per gram of brain tissue

=

l

nmol compound in sample (fractional) ( g tissue
recovery
per samp le
The specific activiti es (DPM/nmol) for Trp and 5-HT were
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calculated and used in the determinatio n of turnover rate constants
.f or 5-HT based on the eq uat i on of Neff et

(1971).

aZ .

The turnover

rate was determined by the steady state equation for the change in
5- HT concentratio n, d5 - HT/ dt = K (Trp-5HT ).

This equation ca n be

rearra nged to:
K = [ (5 HT t -5HTt )/(t 2- t 1 )]/([(Trp - 5HT )t + (Trp - 5HT)t ]/2)
2
1
1
2
where:
K = co nstant for the turnover rate of 5HT
5HTt , 5HTt = 5HT specific activity at 1 and 2 hours,
1

2

resp ective ly, after 3H- Trp injection
tj, t 2 = 1 and 2 hours, respectively
5-HT turnover rate = k[5 -HT]
A s ingle-factor analysis of variance was employed to anal yze
the effect of the vario us test compounds.

Sign ifi cant differences

among treatment means (p < 0.05) were calculated by a Tukey's - HSD
multiple mean comparison test (Neter and Wasserman, 1974).
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RESULTS
The objective of this study was to assess the biochemical status
of the brain 5-HT pathway after in vivo exposure to a series of
occupatio nal neurotoxic compounds including 2,5 -hexanedione,
acry l amide, tri-o - tolyl phosphate, Leptophos and Me - Hg.

Preliminary

i nvestigat i ons of neurotoxic indices, as measured by performance on
the rotorod, were necessary to establish optimal dose pe r iods and
levels fo r each compound.
Roto rod Studies
In animals gavaged with 2,5 - he xa nedio ne, a high mortality rate
was seen in the 3.0 g/kg/day group, with 80% of the rats dead by the
third day while 1 rat in the 1 g/kg group died on day five (F ig. 2).
Because of these deaths, dosing was discontinued in the 3.0 g/kg
group after day three and in the 1. 0 g/kg animals after day 4.
The animals given dail y doses of 0. 3 g/kg showed a gradual loss
of coordinatio n on the rotorod with compl ete failure seen in all
animals after the fifth day .

No tremors were observed in the animals

at any dose level and the 0.3 g/kg/day dosed-group showed a slightly
higher weight gain than those animals given equal volumes of
propylene glycol only (Table 3) .
Acrylamide-treated rats at the lower dose levels had l i ttle
difficulty in maintaining their balance on the rotorod (Fig. 3),
while animals in the 50 mg/kg group exhibited a time-related
decrease in performa nce with signs of tremors by the fourth day,
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Q)

.:

control

60

1'0
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~
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0.3 g/kg - - \1.0 g/kg ---- 3.0 g/kg - · -

40

20

0

2

3

4

5

6

Days of 2,5 - hexanedlone Dos ing

FIG. 2. Percent age of rats unable to remain on the rotorod for 60 seconds at
20 RPM prior to 2,5-hexanedione dosages (n = 5 in each group}. The animals were
dosed daily. Two animals in the 3g/kg group died .on both days 2 and 3 while one
died in the lg/k·g group on day 5. Dosing was discontinued in the 3.0 g/kg group
after day 3 and i n the 1.0 g/kg group af t er day 4.
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TABLE 3
RAT \'EIGHT CHANGES FR011 DAY OF THE FIRST DOSE
TO THE DAY OF SACRIFIC E
Duratio n of
Treatment
(Days)
2,5 hexanedione (mg/ kg)
Ce nt ro 1
30
100
300

8

Acryl ami de
Contra 1
5
15
50

6

Anima l Weights (g)b
Initi al
192
187
191
186

%

change

Fi nal

3
3
4
4

224 ± 6
226 ± 4
219 ± 5
211 ± 4

+
+
+
+

17
21
15
13

236 ± 1
234 ± 4
237 ± 5
241 ± 4

272 ± 3
267 ± 4
278 ± 3
271 ± 3

+
+
+
+

15
14
17
12

182 ± 3
183 ± 4
185 ± 2
174 ± 3

283 ± 4
282 ± 4
288 ± 4
272 ± 5

+
+
+
+

55
54
56
56

234 ± 6
228 ± 5
233 ± 3
235 ± 5

322 ± 9
311 ± 6
311 ± 9
293 ± 6

+
+
+
+

38
36
33
25

218 ± 3
223 ± 5
226 ± 3
226 :!: 3

285
293
296
275

4
7
6
5

+
+
+
+

30
31
31
22

±
±
±
±

17

TOTP
Control
30
100
300
Leptophos
Co ntra 1
4.5
15 . 0
45.0

14

Me- Hg

14
Centro 1
1.0
3.3
1.0

±
±
±
±

al4 animals in each treatme nt group except acrylamide which had 16
animals per group.
bWeights in grams are shown as mean± S.E .

control
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15 m g/kg - - - 50 mg/kg - · -
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FIG. 3. Percentage of rats unable to remain on the rotorod for 60 seconds at
20 RPM prior to acrylamide dosages (n = 5 in each group). The animals were dosed
daily .
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until they were unable to walk on the rotorod by day six.

Weight

gains in the acrylamide-treated animals were similar to gains. in
2,5-hexanedione-fed rats with a 12% increase in the high-dose
gro up compared to a 15% gai n in control animals while the other dose
groups increases were similar to control values (Table 3).
TOTP had a severe effect on animals given oral doses of l .0
g/kg.

The entire group died within two days after the first dose was

given.

Rats i n the 0.33 g/kg group were affected in their attempts

at the rotorod and by the sixteenth day, all showed slight tremors
and none were able to perform satisfactorily on the rotorod (Fig.
4).

During the same time per iod, treatments with 0.1 g TOTP/kg

caused no impairment in rotorod performance.

TOTP had no effect

on weight gain at any of the dose levels studied (Table 3).
Leptophos-treated animals showed signs of tremors after the
first dose of 90 mg/ kg .

Two animals in that group died after the

third atropi ne dose but prior to oral administration of the
Leptophos.

Dosing was then discontinued because the general

appearance of the animals showed they were very lethargic and
emaciated .

Anima ls dosed with either 30 mg/kg or 9 mg/kg had

little difficulty performing the rotorod test for a total of six
doses in sixteen days (Fig. 5).

Animals in the 45 mg/kg dose group

showed a 25 % weight gain in sixteen days compared to 38% in control
animals (Table 3).

Leptophos had no effect on weight ga in at lower

dose levels .
Time- and dose-related responses were seen in methyl mercurytreated animals.

By the sixteenth day, animals given doses of

10 mg/kg failed completely while attempting to wa l k on the rotorod
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0.10 g/kg - - 0.33 g/kg - - - -
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FIG. 4. Percentage of rats unable to remain on the rotorod for 60 seconds at
20 · RPM prior to TOTP dosages (n = 5 in each gro up) . The anima l s were dosed
every third day .
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FIG . 5. Percentage of rats unable to remain on the rotorod for 60 seconds at
20 RPM prior to Leptophos dosages (n = 4 in each group). The anima l s were dosed
every third day. Dosing was discontinued in the 90 mg/kg group after day 7.
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(Fi g. 6).

At the same time ra t s in the 5.0 mg/kg and 2.5 mg/kg

trea tment groups showed 60% and 40% failure rates, respectively.
A 22% weight gain was seen in th e 1 .0 g Me-Hg/kg group compared
to gains in co ntrol and other treated ani mals of 31 % (Ta bl e 3).
Biochemical Studies
These studies were do ne with brai ns of a separate group of
animals treated in vivo with vario us chemicals at the doses
established by rotorod testing.

Animal s dosed with 2,5-hexanedione

showed no sig ni f i cant differences fro m co ntrol animals in levels
of Trp or 5-HT (Table 4).

Serotonin tu rnover rates dec li ned

slightly in both the 30 mg/ kg and 100 mg /kg dose level s, but
the 300 mg 2,5-HD/kg-treated animals had· tu rnover rates equal to
co ntrol values.

At the 30 mg/ kg dose, level s of 5-H IAA were

slightl y higher (1. 81 nmol /g) than control values , (1. 59 nmol /g) ,
whi le both the 100 mg/k g and 300 mg/kg treated animals had 5-HIAA
va lues which were significa nt ly differe nt (p

<

0.05) f rom propylene

glyco l- treated an imals (F ig. 7).
Acrylamide -treated animals showed co ns ta nt levels of Trp and
5-HT with no differences in serotonin turnover rates compared to
va lues in control animals (Table 5).

Aga in, 5-HIAA levels in creased

in a dose-dependent manner with the two highest dose levels, 15 and
50 mg acrylamide/ day, showing significant differences (p < 0.05)
from contro l animals (Fig . 8).
Levels of endogenous indole compounds in the brains of TOTPtreated ani ma l s showed no effect ( init i al 6%, non-s ig ni ficant in crease ) onTrp levels in the 30 and 100 mg TOTP/kg dose groups while

con trol

100

,.--·--·-

2.5 mg/kg
5.0 mg/kg
10.0 mg/kg - · -
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Cl)
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I
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FIG. 6. Percentage of rats unabl e to remain on t he rotorod for 60 seconds at
20 RPM prior to Me-Hg dosages (n = 5 in each group). The animals were dosed
every third day.

TABLE 4
WHOLE BRAIN LEVELS OF ENDOGENOUS INDOLE COMPOUNDS AND 5- HT TURNOVER RATES
AFTER 2, 5-H EXANED IONE TREAT11ENT in vivo a
2,5-he xaned i one (mg/kg)
Control
Tryptophanb

30

300

100

24.03

±

0.75

23.78

±

0. 57

24.42

±

0.83

24.87

±

0.90

5-HTb

2.75

±

0.07

2.69

±

0 .07

2.82

±

0.05

2.67

±

0 .09

5-HIAAb

l. 59 ± 0 . 11

1 .81

±

0.07

l. 98 ± O.lOd

5-HT turnover ratec

2.01

1.90

±

0.11

1.82

±

0.08

±

0. 12

al4 animals in each treatment group.
bConcentrations are expressed as nmol/g.
cRates are expressed as nmol/g/hr.
dSignifi cantly different (p

<

Da ta are shown as means ± S. E.

Data are shown as mean ± S.E.

0.05) from control values .

0.08d

2.02
l. 98

l

0.08

2.5

01

2.0

*

*

<(

~

J:

1.5

II)

0

1.0

E
c:

0.5

2,5 - hexandione dosage (mg/kg)
FIG. 7. Levels of rat brai n 5-HIAA l eve l s af ter 2,5-hexanedione administration
for 7 consecutive days . The vertical bars represent the standard error of the
mean; n = 14 in each dose level . Asterisk ind i cates a significant difference
(p < 0.05 ) from control values.

TABLE 5
WHOLE BRAIN LEVELS OF ENDOGENOUS INDOLE COMPOUNDS AND 5- HT TURNOVER RATES
AFTER ACRYLAt~IDE TREATI 1ENT In v·ivoa
Acryl ami de (mg/kg)
Contra 1

5

15

23.38 ± 0.54

22.78 ± 0. 72

23.00 ± 0.57

5-HTb

2.56 ± 0. 05

2.60 ± 0.04

2.69 ± 0.05

2.58 ± 0 .04

5-HIAAb

1 .68 ± 0.03

l. 90 ± 0. 07

2. 16 ± 0.08d

2.30 ± 0 .05d

5-HT turnover ratec

1.88 ± 0.07

2.02 ± 0.10

l. 94

l. 95 ± 0.10

Trypto phan b

al4 animals in each treatment group
bConcentrations are expressed as nmol/g .
cRates are expressed as nmol/g/hr.
dSignificant ly different (p

<

Data are shown as mean ± S.E .

Data are shown as mean ± S.E.

0.05) from contro l values

±

50

0.08

23.05

±

0.63

2.5

Cl

*

*

2.0

c:(
c:(

:I:

1.5

10

0

1.0

E
c::::

0.5

Acrylamide dosage (mg/kg)

FIG. 8 . Levels of rat brain 5-Hl.AA levels after acrylamide administration for 5
consecutive days. The vertical bars represent the standard error of the mean; n = 16
in each dose level . Asterisk indi ca tes a signi ficant differen ce {p < 0.05) from
control values.

45
the 300 mg/kg-treated animals had values very close to those of
control animals (Table 6).

Serotonin levels were unchanged

throughout the doses studied and 5-HIAA levels were slightly {6%)
lower in the two higher dose groups.

Serotonin turnover rates showed

a non-s ign ifica nt, dose-dependent increase to a maximum of 10%
over contra 1 va 1ues.
In rats gavaged with Leptophos, 1evel s of tryptophan and 5-HT
remained unchanged.

Serotonin turnover rates were similar to those

seen in TOTP - treated animals with values slightly, but
non-significantly, higher than co ntrol values (Ta ble 7).

A bimodal

trend was seen i n the 5- HIAA levels with an initial increase in
animals dosed with 4.5 mg and 15 mg Leptophos/kg followed by
concentrations less than control values at 45 mg/kg.
Levels of indole compounds in Me-Hg treated rats (Table 8)
showed no significant differences from co ntrol values; however, the
turnover rates and levels of 5-HT were lower in the 1.0 and 3.3
mg/k g dose groups, while the highest mercury dose level had no
effect on turnover rates or concentration.

TABLE 6
l~HOLE

BRAIN LEVELS OF ENDOGENOUS INDOLE COMPOUNDS AND 5-HT TURNOVER RATES
TRI-0-TOLYL PHOSPHATE TREATMENT in vivoa
Tri-0-tolyl phosphate (mg/kg)
Control

Tryptophanb

30

100

300

22 .62

±

0.81

24.01

±

0. 72

24.12

±

0.87

22.98

±

0 .93

5-HTb

2.6 7

±

0 .05

2.61

±

0.05

2.73

±

0.08

2.63

±

0.07

5-HIAAb

1 . 72

±

0.08

1. 78

±

0.12

1 .67

±

0.07

1 .61

±

0.08

5-HT turnover ratec

l. 95 ± 0. 11

1. 99

±

0.06

2.05

±

0.09

2.15

±

0. 12

al4 anima l s in each treatment group .
bConcentrations are expressed as nmol/g.
cRates are expressed as nmol /g/hr.

Data are s hown as mean s

Data are shown as mean ± S. E.

±

S.E.

TABLE 7
WHOL E BRAIN LEVELS OF ENDOGENOUS INDOLE COMPOUNDS AND 5- HT TURNOVER RATES
P.FTER lEPTOPHOS TREATMENT ·i n v·i voa
Leptopho s (mg/kg)
Contro l
Tryptopha nb

45

15

4. 5

23.07

±

0.97

24.87

±

0.82

22 .9 2

±

1.04

23.23

±

0 .86

5-HTb

2. 72

±

0.07

2.63

±

0.09

2. 69

±

0,05

2. 78

±

0 .11

5-HIAAb

l. 52 ± 0.08

1. 67

±

0.15

l. 59 ± 0.07

1.43

±

0 .1 0

5-HT t urnover ratec

1. 88

1. 96

±

0.05

l. 58 ± 0.05

2.07

±

0.10

±

0. 09

al4 animals in each treatment group.
bConcentrations are expressed as nmol/g.
cRates are expressed as nniDl/g/hr .

Data are shown as mea ns

Data are shown as mean

±

S. E.

±

S .E.

-~~--

TABLE 8
WHOL E BRAIN LEV ELS OF ENDOGE NOUS INDOLE COMPOUNDS AND 5-HT TURNOVER RATES
AFTER ~1e-H g TREATMENT i n vivoa
Me-Hg (mg/kg )
Contro l
Tryptop hanb

1.0

3.3

10.0

22.63

±

0. 77

23.05

±

0.65

22.87

±

0.92

22.79

±

0 .75

5- HTb

2.65

±

0.07

2. 77

±

0.09

2.56

±

0 .07

2.69

±

0.05

5- HIAAb

1. 70

±

0.06

1.62

±

0.08

1.77

±

0. 14

1.60

±

0.09

5-HT turnover ratec

1. 90

±

0.15

1. 78

±

0. 11

1. 75

±

0.08

1. 95 ± 0.11

al4 animals in each treatment group .
bConcentrations are expressed as nmo l /g.
cRates are expressed as nmol/g/hr .

Data are shown as mea ns

Data are shown as mean

±

S.E.

±

S. E.
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DISCUSSION
Rotorod Studies
The initial training period of 7 to 10 days was accomplished
with little difficulty in most rats.

Occasionally, a rat in a

group could not walk on the rotorod for the prescribed period of
time, but because the animals were selected randomly, all animals
were used in the analysis which accounts for many of the failures
reported in control and low dose groups .
In the 2,5-HD study, 80% of the rats in the 3.0 g/kg/day
treatment group died by the third day.

The l .0 g/kg/day group lost

all coordination in walking the rotorod by the third day.

By day

five they were showing slight signs of tremor and one animal died .
The 0.3 g/kg dose group exhibited a gradual decline in their ability
to walk the rotorod and on the fifth day none of the animals in this
group could remain on the rotorod for the prescribed time period.

A

level of 300 mg/kg/day to be administered seven consecutive days was
designated as the high dose group with 100 mg/kg and 30 mg/kg
doses given concurrently.
Cumulative doses of 380 mg/kg acrylamide (Gipon et al., 1977)
and 420 mg/kg acrylamide (Kaplan and Murphy, 1972) have been reported
to produce deficits on the rotorod
tremors .

with accompanying muscular

These experiments used dosing regimes similar to the

present study, which showed consistent rotorod failures at a
cumulative dose of 300 mg/kg.
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The acrylamide - induced muscular weakness obs erved in these
experiments could be secondary to decreases i n body weigh t .
Schotman et al . (1977a ) fou nd that pair-fed controls had higher
weight gains than acrylamide treated rats.

Although food intake

is reduced during acrylamide intoxication (Gipon et al ., 1977),
tryptophan levels in the present study were consistent with contro l
values at all dosages of test chemicals .
Acrylamide-treated animals (SO mg/kg/day ) showed tremors on
the fourth consecutive day of treatment and could not satisfactorily
complete the rotorod testing by the fifth day.

These results

indicated an acrylamide regime, lasting five days with the same dose
levels used in the rotorod testing, wou l d be satisfactory for
biochemical studies.
All TOTP-treated ani mals in the high dose group (1 .0 g/kg)
died after the first gavage.

At 0.33 g/kg, given every three days,

the animals showed a gradual dec l ine in rotorod performance with
complete failure at day 16 while the 0.10 g/kg group had no problems
with rotorod performance.

The 300 mg/kg level

was se l ected as the

highest dosage for the biochemical studies with 100 mg/kg and 30
mg/kg given as the medium and low doses to be given in six doses
every third day .
Leptophos animals did not do we ll phys i ol ogica ll y at the
90 mg/kg level .

Tremors we r e seen in all animals before the second

dose, whi le two animals of that group di ed after atropine injections
on the seventh day .

The anima l s in the 30 mg/kg group were stil l

doing rather well in the rotorod testing by the sixteenth day.

A

sli ghtly higher dose of 45 mg/kg , to be give n in five doses every
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third day , was chosen as the highest level for the brain chemica l
studies with leve l s of 15 mg/ kg and 4.5 mg / kg also given through the
same time period.
Methylmercury-treated anima l s exhibited a dose-related response
At a dose of 10 mg methylmercury/kg,

in rotorod performance.

given every 3 days, the animal s reached 100% failure on the rotorod
before the fifth dose on the thirteenth day, while the 5 mg/kg and
2.5 mg/kg animals had failure rates of 60% and 40%, respectively,
after f i ve doses .

These same dose levels were chosen for the brain

chemica l assays and were administered in five doses every third day.
The rotorod seemed to be a reliable indicator of neuromuscular
deficiency.

As a too l for assessment of clinical neuropathy, it

requires very little familiarity by the operator or training such
as is required by more indepth psychological studies.

Other tests

such as hindlimb extensor tests and forelimb grasp tests seem to be
somewhat more sensitive and specific (Tilso n and Cabe, 1979;
Tilson et al. , 1980), but also requ ire specialized expens i ve
equipment.

The purpose of the rotorod testing was to establish

doses for the subsequent biochemical studies and the rotorod has
provided sufficient information to answer those questions.
Biochemical Studies
Whole brain levels of endogenous indole compounds as well as
5-HT t urnover rates compared very closel y with reported literature
va lues .
23. 14

±

The average values in this laboratory for Trp were
0.56 nmol/g, while 5-HT averaged 2.67

5-HIAA levels were 1.64

±

0.06 nmol/g.

±

0.08 nmol / g and

Smith et al. (1975) have
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reported values for Trp, 5-HT and 5-HIAA of 15.6 nmol / g, 2.5 nmol/g
and 1.7 nmol / g, respe ctive ly, while Marini et al . (1979 ) reported
average values of 22.5 nmol / g for Trp, 2.4 nmol / g for 5-HT and
1.95 nmol / g for 5- HIAA.

Rates of 5-HT turnover have been reported

as 1.5 nmol /g/ hr in whole rat brai n by Neff et al. (1971) and as
2.32 nmol /g/ hr (Tozer et al. , 1966 ).
A conside ration in establishing the dosing regime fo r the
biochemical stud ies was t hat they not have a prolonged ti me period
because of the difficulty involved in tail vein injections of rats
exceeding 350 g.

However, the dosing durations used were sufficient

to produce clinical neuropathy, in at least one dose level .
While Gilles et al. (198la, 198lb ) demo nstrated an inhibition of
lipid meta bolism and stero logenesis in rats after a 6 week exposure
to 1% 2, 5-HD in drinking water, 5-HT and 5-HIAA levels in ra ts and
hamsters i ncreased afte r s i ng le exposure to die ld r in followed by
sacrifice either a day or a week later (Kohli et al. , 1977;
Willhite and Sharma, 1978) and within 2-6 hrs after a single
carbaryl do se (Hassan and Santolucito, 1971 ).

These studies indicate

t he ability of the 5-HT pathway to respond rapidl y after toxic
chemical exposure.

Nevertheles s , lack of biochemical activity at

the dose levels used in these studies doesn't ruleout the possibility
that an effect may be seen at lower dose levels over a l onger period
of time.
Normally, brain 5-HT is almost qua ntitati ve ly co nverted to
5-HIAA (Tozer et al ., 1966 ).

The pial 1ining of the adult brain

offers li ttle resistance to the passage of acid metabol ites to the
cerebrosp i na 1 fluid ( CSF) compartments ( Cserr, 1974 and Fenstermacher
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et aZ ., 1974).

The CSF system has low concentrations of acid

metabolites relative to hi gh levels in brain interstitial fluid.
This rela tionship was proposed to serve as a "diffusional sink" or
"quasi-lymphatic system" for the elimination of 5-HIAA from brain
(Meek and Neff, 1973; Oldendorf and Oavson, 1967) .

In the 30 day

old rat, the rate of 5- HIAA formation is about 4.2 ng/brain /m in
and CSF concentrations of 5-H IAA are 126 ng/ml.

Complete clearance

of the acid metabo lite would require a bulk flow rate of 33

~ 1 / min,

whereas the circulatory rate for CSF can account for no more than
6% of the 5- HIAA elimination (Bass and Lundberg, 1976 ).

These

researchers showed that the transfer of the organic acid to
ventricular CSF and their subsequent active tra ns port to blood via
the choroid plexus i s not the major route for removal of 5-HIAA
from the whole brain, although those areas situated proximal to the
ve ntricle may depend on this route.

They found the efflux rate

from the CSF was too slow to ac count for the entire 5- HIAA clearance
and demonstrated an active transport system at the glia-capillary
interphase which accounted for the efflux of 75% of the 5-HI AA
formed in the brain.
Since the leve ls of Trp and 5-HT as well as the 5-HT turnover
rates were not significantly changed with any of the dosa ges of
acrylamide and 2,5-HD used in this study, and while the 5-H IAA levels
increased in a dose-dependent manner, it is possible the energydependent carr ier-mediated acid transport efflux system from the
bra in to the cerebral spinal fluid or the blood stream via glia l
cells may have been affected.

Aldous et aZ . (1981) found a similar

significant increase in 3,5-dihydroxyphenylacetic acid (DO PAC ), a
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major DA metabolite, with the same regime of acrylamide administration
used in th is study, while no apparent changes in levels or turnover
rates of DA were seen.

Based on the resul ts of several studies of

glycolytic enzymes, Spencer and co-workers (1979) have hypothesized
neurotoxic compounds (acrylamide and neurotoxic hexacarbons), that
cause central-peripheral distal axonopathy, deplete energy supplies
in the nerve fiber by inhibiting enzymes required for energy synthesis
leading to a blockage of energy-dependent axonal transport .
The organophosphorus-dosed animals showed no significant changes
in Trp, 5-HT and 5-HIAA levels when compared to control animals
although there were dose-related increases in 5-HT turnover rates
and endogenous 5-HT with a decrease of similar magnitude in 5-H IAA
levels, indicating a possible MAO inhibition.

Chickens or cats are

much more sensitive to neurotoxic organophosphate compounds than
rats (Davis and Richa rdson, 1980) and perhaps the methods employed
in this study should be adapted to one of these species for further
clarification.
Methylmercury-treated rats were not significantly different from
control an imal s with respect to leve ls of indole compounds, although
turnover rates were slightly lower in animals fed either 1. 0 or 3.3
mg/kg .

Other studies have shown methylmercury causes damage in the

rat blood-brain barrier (Ware et al., 1974) with a resultant
reduction of amino acid uptake in the brain (Steinwa ll and Klatzo,
1966), as well as reduced brain levels of 5-HT in neonatal rats .
The results indicate that at the dose levels and period of
administration used in the present study, methylmercuric chloride
has no effect on Trp uptake or synthesis and meta bolism of 5-HT.

55
Dieta ry availability of Trp and inter ference with the Trp
tra nsport processes at the blood-brai n barrier both alter brain 5- HT
synthesis (Fernstrom, 1979 ),

Acrylamide (2D mg/kg) has been shown

to reduce brain membrane protein levels (Ag rawal et aZ. , 1981).
Since whole bra in Trp levels were not sig nificantly changed with
any of the test compounds in this study, the availability of amino
acid precursors was not a factor, even in those animals with weight
gains much less than controls.

Anima ls with musc le tremo rs apparentl y

consumed enough food to mai ntain a proper amino acid balance.

No

demonstrated loss of functional integr ity was observed in the
blood-brain barrier with regard to Trp transport.
Discrete brain areas show varied concentrations of 5-HT with
representative values

(~g/g)

for various brain areas being 2,03 in

the hypotha lamus, 1.1 1 in the po ns -medulla , l .10 in the midbrain, the
ca udate-putamen area is 1,05, the hippocampus values average 0. 57
while the cortex and cerebellum values are 0.49 and 0.33, respectively
(Jacobowitz and Richardson, 1978).

Gothoni and Ahtee (1 980) found a

significant decrease in 5-HT concentrations in the section of the
brain contai ni ng the pons and medulla oblongata with an increase in
5-HIAA levels in these areas .
unchainged .

The values in the cortex remained

Nickel also decreases 5-HT levels in the basal ganglia

(Ali et aZ ., 1980) with similar changes in the cerebral cortex .

The

present study invo lving whole brain showed no significant changes in
5-HT co ncent rat ions or 5-HT turnover ra te.

A study involving

5-HT- rich brain areas may show some changes which were possibl y
masked by

•t~hole

brain va lues.

56

SUMMARY AND CONCLUSIONS
This investigation was initiated to determine if in vivo
exposure to several industrial and/or environmental chemicals
affects endogenous whole brain levels of Trp, 5-HT and 5-HIAA as
well as 5-HT tu rno ver rates in rats.

Preliminary experiments using

a rotorod apparatus, fitted with an electrode floor, were performed
to establish dosage levels and duration of exposure .

The rotorod

procedure used in this study, provided an adequate clinical
indication of neuropathy although discrimi nation between fore - and
hind- l imb deficits were not possible.
Levels of endogenous indole compounds were determined
spectrofluorometrically and specific activit i es of Tr p and 5-HT
were determined at both one and two hours after 3H-Tr p IV injection .
The data show a dose -dependent increase in 5-HIAA levels while
5-HT and Trp values as well as 5-HT turnover rates showed no
significant differences from control levels in animals treated
with either acrylamide or 2,5-hexanedio ne .

These results suggest

an inhibition of the energy-dependent acid efflux system from the
brain to the cerebral spinal fluid or to the blood stream.
None of the chemicals used in this study altered the whole
brain levels of Tr p, indicating no effect on dietary status or
subsequent Trp tra nsport across the blood brain barrier, although
some animals did show weight ga ins much less than controls.
Animals dosed with either TOTP, Leptophos or Me-Hg had no
significant changes in the parameters studied although TOTP and
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Leptophos treated animals showed slight, dose-dependent, increases
in 5-HT turnover rates with insignificant decreases seen in 5-HIAA
levels.

Since chickens or cats are more sensitive to organophosphorus

neuropathy than rats , investigation in these species may provide
evidence for influence of indole metabolism.
No significant changes in 5-HT synthesis in metabolism were
seen in animals treated with Me-Hg .

Since Trp levels in t hese rats

were similar in control and treated rats, there is no evidence of
commonly observed Me- Hg-induced blood - brain barrier damage at the
dose levels used in this study.
Further studies involving longer dose periods or examination
of discrete brain areas may further clarify the effects of these
chemicals on brain biochemistry ,
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